Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.
Zhongguancun Shuimu Medical Technology is a third-party medical device inspection and testing institution.
Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle.
Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development.
Libo Biotech is a company focused on developing innovative small molecule drugs targeting RNA.
Excalipoint Therapeutics is a Private limited company.
Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.
Xijian Technology is committed to advancing the industrialization of innovative human biomechanics imaging technology.
Cantai Therapeutics operates as a developer of drug candidates.
CryOSA is a medical device company developing novel treatments for obstructive sleep apnea.
Shuwen Biotech is engaged in licensing and developing innovative diagnostic products and services for disease prevention.
Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience.
Infinity Bio is a biotech company that offers analytics and insight services for antibody reactome profiling against all human viruses.
Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.
Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function.
UltraClear is a skincare clinic that provides facial rejuvenation solutions for the treatment of all skin types.
Dermaliq's mission is to develop and sell the next generation of dermatology treatments for patients with severe unmet medical needs.
Junhemeng is a research and development company of recombinant protein drugs.
Sipeng Technology is a new form of synthetic biology high-tech company.
Hillhurst develops technologies enabling the therapeutic use of low-dose carbon monoxide.
Kossel Medical is a medical device R&D, manufacturer of vascular interventional devices to provide clinical system solutions.
Shanhai Innovation is a medical science company that provides supramolecular science and technology research and development solutions.
Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations.
Apeximmune Therapeutics engages in the discovery and development of novel biologics that modulate the immune system.
BioVenture has invested in 273 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioVenture's top investment sectors include Biotechnology, Medical, Health Care, Pharmaceutical, Therapeutics. The firm invests across 23 different industry categories.
Among tracked funding rounds, Mosanna Therapeutics received $80.0M in a Series A round. BioVenture's total known invested capital is $1.3B.
BioVenture's average investment size is $25.0M across its portfolio of 273 companies.
Recent BioVenture portfolio additions include Navrogen, Zhongguancun Shuimu Medical Technology, Rapafusyn Pharmaceuticals, Hongxin Biology, Libo Biotech. These companies were founded in 2020 or later.